Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event, Trade Show

Axial Biotherapeutics to Participate in 5th Annual BMO Private Company Showcase


Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, today announced that the company will present at the 5th Annual BMO Private Company Showcase on Friday, October 18, 2019 at 9:40 AM ET.

About Axial Biotherapeutics

Axial Biotherapeutics is a clinical stage biopharmaceutical company pioneering novel science focused on the interaction between the brain and the gut to mitigate the causes and symptoms of CNS and other gut-derived diseases. The Company has built a pipeline of novel small-molecules and live biotherapeutics with lead programs to address the significant unmet patient needs associated with Parkinson's Disease and Autism Spectrum Disorder.


These press releases may also interest you

at 05:45
The Gross Law Firm Notifies HireRight Holdings Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - HRT
The Gross Law Firm issues the following notice to shareholders of HireRight Holdings Corporation . Shareholders who purchased shares...

at 05:36
COP28 President urges governments to 'think bigger, act bolder' on national climate plans that are aligned with the UAE Consensus at Petersberg Climate Dialogue
Speaking in the High-Level Segment of the annual Petersberg Climate Dialogue, attended by Chancellor Olaf Scholz, President Ilham Aliyev of Azerbaijan and a number of Climate and Foreign Affairs Minister Ministers, COP28 President Dr Sultan Al Jaber...

at 05:27
London Blockchain Conference Launches the No Future Campaign
The London Blockchain Conference is excited to announce the launch of its ground-breaking, 'No Future Campaign'. This initiative aims to create a strong narrative surrounding blockchain technology by challenging perceptions and sparking...

at 05:12
Sobi establishes MTN programme with a framework amount of SEK 10 billion, publishes a base prospectus
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...

at 05:05
Hikvision redefines urban mobility with AIoT-powered solutions at Intertraffic 2024
Hikvision made a significant appearance at Intertraffic Amsterdam, the leading global trade fair for mobility and traffic technology. At the trade event, Hikvision unveiled a suite of traffic, transport, and parking management solutions and products...

at 05:00
VyOS Networks and Iquall Networks Forge Strategic Collaboration to Advance Network Solutions
VyOS Networks and Iquall Networks are excited to announce a strategic collaboration, marking a significant milestone in their commitment to advancing network solutions. This partnership combines the strengths of both organizations to foster...

More news about Science and technology...


News published on and distributed by: